Please login or register to print this page.

Clinical Articles, Lead Article

WHAT DOES AF REALLY MEAN FOR PATIENTS?

A study which aims to describe adverse events associated with atrial fibrillation (AF) and the drugs used to treat it, has been published in the British Journal of Cardiology (BJC).1

The study conducted by, Oxford Outcomes, looks at the perceived quality of life impact of AF and AF-treatment related adverse events among patients, members of the general public and doctors who regularly treat the condition.

opening-pills-internalThe study shows “clear quality of life impairments associated with treatment-related adverse events” such that people on average stated that they would be willing to sacrifice 12-18 months of life for the avoidance of the worst adverse events (eg hypothyroidism and “pulmonary issues”) associated with typical AF therapies.

Full details of the study, which the authors claim is the first of its kind to focus on the “utility impact” of adverse events associated with AF medications, can be accessed at: http://bjcardio.co.uk/2011/04/public-perception-of-atrial-fibrillation-and-treatment-related-adverse-events-in-the-uk/

Reference

1 Doyle S, Lloyd A, Davis M. Public perception of atrial fibrillation and treatment-related adverse events in the UK. Br J Cardiol 2011;18:88-93.

Published on: May 6, 2011

Members Area

Log in or Register now.

 For healthcare professionals only
Learning sky

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.